InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Oruka Therapeutics, Inc.

ORKA Clue Score22
United States Fiscal year ends December CIK 0000907654 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Lawrence Otto Klein
2 Nov 2026
Chief Executive Officer
Sold after exercise
300
$98.40
$29.52K
Lawrence Otto Klein
2 Nov 2026
Chief Executive Officer
Sold after exercise
756
$97.45
$73.68K
Lawrence Otto Klein
2 Nov 2026
Chief Executive Officer
Sold after exercise
2,442
$96.70
$236.15K
Lawrence Otto Klein
2 Nov 2026
Chief Executive Officer
Sold after exercise
15,036
$95.64
$1.44M
Lawrence Otto Klein
2 Nov 2026
Chief Executive Officer
Sold after exercise
6,466
$94.77
$612.79K
Paul T Quinlan
20 Oct 2026
General Counsel
Sold after exercise
3,000
$79.49
$238.47K
Paul T Quinlan
20 Oct 2026
General Counsel
Sold after exercise
4,100
$78.79
$323.04K
Paul T Quinlan
20 Oct 2026
General Counsel
Sold after exercise
1,000
$77.21
$77.21K
Paul T Quinlan
20 Oct 2026
General Counsel
Sold after exercise
500
$76.12
$38.06K
Paul T Quinlan
20 Oct 2026
General Counsel
Sold after exercise
400
$74.90
$29.96K
Joana Goncalves
15 Oct 2026
Chief Medical Officer
Sold after exercise
200
$77.71
$15.54K
Joana Goncalves
15 Oct 2026
Chief Medical Officer
Sold after exercise
700
$76.67
$53.67K
Joana Goncalves
15 Oct 2026
Chief Medical Officer
Sold after exercise
1,400
$75.48
$105.68K
Joana Goncalves
15 Oct 2026
Chief Medical Officer
Sold after exercise
1,847
$74.69
$137.96K
Joana Goncalves
15 Oct 2026
Chief Medical Officer
Sold after exercise
2,853
$73.89
$210.81K
Arjun Agarwal
12 Oct 2026
Senior Vice President, Finance
Sold after exercise
200
$82.84
$16.57K
Arjun Agarwal
12 Oct 2026
Senior Vice President, Finance
Sold after exercise
1,958
$81.86
$160.27K
Arjun Agarwal
12 Oct 2026
Senior Vice President, Finance
Sold after exercise
2,100
$80.76
$169.60K
Arjun Agarwal
12 Oct 2026
Senior Vice President, Finance
Sold after exercise
5,741
$80.03
$459.45K
Show all 19 transactions →

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 19
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 50,999
History held since 2 Oct 2006